EPO and hemolytic-uremic syndrome: Despite this lack of evidence, it is however conceivable, that in the presence of severe hemolytic anemia in patients with HUS, the stimulation of hematopoiesis by EPO could be beneficial by reducing the need for allogenic erythrocyte transfusion, which carry non-negligible risks (29, 30).